Ingenito, Edward et al
"Emphysematous lung sealant (ELS) therapy reduces CRP, an index of inflammation, in patients with severe emphysema (clinicaltrials.gov #NCT NCT00884962)." European Respiratory Journal
42.Suppl 57
(2013):
P2295.
Web. 28 Mar. 2024.